MedTrace Logo

Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants

NCT00474604 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 209

Last updated 2023-11-27

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as MRI, may help diagnose breast cancer. It may also help doctors predict a patient's response to treatment.

PURPOSE: This clinical trial is studying breast MRI in women with known or suspected breast cancer and in healthy participants.

Conditions

Interventions

PROCEDURE

diffusion-weighted magnetic resonance imaging

A scan will be performed.

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

A scan will be performed.

PROCEDURE

magnetic resonance spectroscopic imaging

A scan will be performed.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • A. Bapsi Chakravarthy, MD · Vanderbilt-Ingram Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2023-04-25
Completion
2023-04-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00474604 on ClinicalTrials.gov